An international research team led by the University of Leeds discovered that L-beta-aminoisobutyric acid (L-BAIBA), a molecule released during exercise, strengthens muscles and improves performance, potentially offering therapeutic benefits for muscle damage in type 2 diabetes. This finding could lead to new treatments aimed at preserving muscle function in chronic conditions like diabetes, enhancing physical performance and quality of life.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



